30 results on '"Trovik, Jone"'
Search Results
2. Corrigendum to “Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease” [EBioMedicine 92 (2023) 104595]
3. Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease
4. Longitudinal effects of adjuvant chemotherapy and lymph node staging on patient-reported outcomes in endometrial cancer survivors: a prospective cohort study
5. Cancer awareness in the general population varies with sex, age and media coverage: A population-based survey with focus on gynecologic cancers
6. A Patient-Clinician James Lind Alliance Partnership to Identify Research Priorities for Hyperemesis Gravidarum
7. High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer
8. Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study
9. Iatrogenic gynaecologic fistula: Characteristics and outcomes after treatment at a national competence centre in Norway
10. Treatment of abnormal uterine bleeding by endometrial ablation: Comparison of treatment in two periods
11. Cure of urovaginal fistula by catheter drainage: Experience from 97 patients treated at a national competence centre
12. Surgical treatment of endometriosis: a five-year hospital cohort
13. Blood steroids are associated with prognosis and fat distribution in endometrial cancer
14. Chromatin organisation and cancer prognosis: a pan-cancer study
15. Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions
16. Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U
17. Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study
18. Prealbumin is a marker of nutritional risk in hyperemesis gravidarum
19. Antiemetics in Hyperemesis gravidarum: too little too late?
20. Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions
21. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas
22. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial
23. ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas
24. SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer
25. Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas
26. Markers for individualised therapy in endometrial carcinoma
27. Improved survival related to changes in endometrial cancer treatment, a 30-year population based perspective
28. Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting
29. Plasma calprotectin concentrations in women with endometrial carcinoma
30. Self-sampled and air-dried cervicovaginal secretions can be used for analyses of mucosal antibodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.